Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022; no adverse event; A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022), PRODUCT STORAGE ERROR (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022) and NO ADVERSE EVENT (no adverse event) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M21A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFR (First dose; lot number: EW0186) on 12-Aug-2021, PFR (Second dose; lot number: FD0809) on 02-Sep-2021 and PFR (First booster; lot number: 014F21A) on 08-Nov-2021. Past adverse reactions to the above products included No adverse effect with PFR, PFR and PFR.    On 26-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022), PRODUCT STORAGE ERROR (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022) and PRODUCT STORAGE ERROR (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022).    No concomitant medications were reported.  A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines. They want to know what their next step would be for these patients. Lot number 004M21A, expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022 (40 doses), 04Aug2022 (1 dose), 19Aug2022 (1 dose), 30Sep2022 (1 dose).  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704299, US-MODERNATX, INC.-MOD-2023-704300, US-MODERNATX, INC.-MOD-2023-704320, US-MODERNATX, INC.-MOD-2023-704301, US-MODERNATX, INC.-MOD-2023-704316, US-MODERNATX, INC.-MOD-2023-704315, US-MODERNATX, INC.-MOD-2023-704314, US-MODERNATX, INC.-MOD-2023-704305, US-MODERNATX, INC.-MOD-2023-704355, US-MODERNATX, INC.-MOD-2023-704369, US-MODERNATX, INC.-MOD-2023-704397, US-MODERNATX, INC.-MOD-2023-704398, US-MODERNATX, INC.-MOD-2023-704399, US-MODERNATX, INC.-MOD-2023-704327, US-MODERNATX, INC.-MOD-2023-704339, US-MODERNATX, INC.-MOD-2023-703265, US-MODERNATX, INC.-MOD-2023-704332, US-MODERNATX, INC.-MOD-2023-704345, US-MODERNATX, INC.-MOD-2023-704346, US-MODERNATX, INC.-MOD-2023-704347, US-MODERNATX, INC.-MOD-2023-704334, US-MODERNATX, INC.-MOD-2023-704312, US-MODERNATX, INC.-MOD-2023-704318, US-MODERNATX, INC.-MOD-2023-704319, US-MODERNATX, INC.-MOD-2023-704321 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Narrative updated On 24-Jan-2023: Patient identifier details updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704299:Master Case US-MODERNATX, INC.-MOD-2023-704300:(Master case) US-MODERNATX, INC.-MOD-2023-704301:Master case US-MODERNATX, INC.-MOD-2023-704315:Master case US-MODERNATX, INC.-MOD-2023-704316:Master case US-MODERNATX, INC.-MOD-2023-704305:master case US-MODERNATX, INC.-MOD-2023-704314:Master case US-MODERNATX, INC.-MOD-2023-704320:Maste case US-MODERNATX, INC.-MOD-2023-704339:Master case US-MODERNATX, INC.-MOD-2023-704334:Master case US-MODERNATX, INC.-MOD-2023-704399:Master case US-MODERNATX, INC.-MOD-2023-703265:Master case US-MODERNATX, INC.-MOD-2023-704397:Master case US-MODERNATX, INC.-MOD-2023-704369:Master case US-MODERNATX, INC.-MOD-2023-704355:(Master case) US-MODERNATX, INC.-MOD-2023-704327:master case US-MODERNATX, INC.-MOD-2023-704347:Master Case US-MODERNATX, INC.-MOD-2023-704346:Master case US-MODERNATX, INC.-MOD-2023-704345:Master case US-MODERNATX, INC.-MOD-2023-704398:Master case US-MODERNATX, INC.-MOD-2023-704332:Master case US-MODERNATX, INC.-MOD-2023-704312: US-MODERNATX, INC.-MOD-2023-704318: US-MODERNATX, INC.-MOD-2023-704319: US-MODERNATX, INC.-MOD-2023-704321: